Exscientia
AI drug design (listed, merged Recursion)
English-friendly culture & foreign staff visible — sponsorship probable, confirm in interview. Only the company can confirm it.
At a glance
- Industry
- Biotech
- Stage
- public
- Raised
- $500M
- Team
- 251-500
- Based in
- Oxford, United Kingdom
More sponsors in United Kingdom
- HealxAI drug discovery for rare disease
- AstraZenecaBiopharma; large data science & AI (listed)
- GSKPharma & consumer health; AI/ML org (listed)
- Oxford NanoporeDNA/RNA sequencing tech (listed)
- Benevolent AIAI-driven drug discovery (listed)
- CongenicaGenomic analysis & diagnostics software
- Genomics EnglandNational genomics data & research
Compiled from public information, role counts as of 8 Nov 2026. Always confirm visa sponsorship and pay directly with Exscientia.